share_log

上海君澜律师事务所关于毕得医药2024年激励计划首次授予限制性股票相关事项之法律意见书

Legal Opinion of Shanghai Junlan Law Firm on matters relating to the first granting of restricted shares in Bide Pharmaceutical\'s 2024 Incentive Plan

SZSI ·  Jan 9
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more